Advanced search×

A harmless high?

Esther M Sammler, Peter L Foley, Gavin D Lauder, Simon J Wilson, Andrew R Goudie, and Jonathan I O'Riordan

Lancet 376(9742):742 (2010) PMID 20801405

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/S0140-6736(10)60891-4
Version: za2963e q8za6 q8zbe q8zca q8zd5 q8ze4 q8zf2 q8zgd

Similar articles you may find interesting…

  1. Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression.
    Rochelle M Hines, Longjun Wu, ... Alaa El-Husseini

    J Neurosci 28(24):6055-67 (2008) PMID 18550748

    We use transgenic mouse models expressing NL1 or NL2 to examine whether enhanced expression of specific NLs results in synaptic imbalance and altered neuronal excitability and animal behavior. Our analysis reveals several abnormalities selectively manifested in transgenic mice with enhanced expressi...
  2. [Neuropathology of frontotemporal dementia].
    Shigeo S Murayama

    Rinsho Shinkeigaku 48(11):998 (2008) PMID 19198143

    I as PiD with Pick bodies (three repeat tauopathy), type II as corticobasal degeneration (CBD, four repeat tauopathy) and type III as FTLD with ubiquitinated inclusions (FTLD-U). The recent progress provided an evidence that the majority of FTLD-U represented primary TDP 43 proteionopathy. Three maj...
  3. Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress.
    Martin W MW McBride, M Julia MJ Brosnan, ... Anna F AF Dominiczak

    Hypertension 45(4):786-92 (2005) PMID 15699453